Recently, we ran a poll on LinkedIn asking professionals across life sciences a simple question: Is mid-career talent becoming harder to find compared to early-career and senior candidates?
- 40% said yes, consistently
- 34% said occasionally
- 26% said rarely or never
This echoed our own experience at Mix, which is that in between early-career professional and highly tenured leaders sits a thinner-than-expected cohort.
This group is made up of professionals with roughly 7–12 years of experience: seasoned enough to take on greater responsibility, mentor others, and step into senior individual contributor or first-line leadership roles, and yet noticeably harder to find.
At Mix, we’ve started referring to this phenomenon as the “missing millennial middle.” Understanding how this gap formed – and what can be done about it – is important for candidates navigating their careers and for life sciences organizations working to build strong, sustainable commercial teams.
What caused the gap?
This gap is not about individual choices as much as it is about timing, structural shifts, and how the industry has historically managed risk, including…
Entering the industry during a volatile period
Many professionals now expected to be in mid-career roles entered pharma between 2008 and 2015 – a time of meaningful change across the industry.
Early disruption led to non-linear paths
Many millennial professionals experienced one or more layoffs early in their careers, lateral moves instead of upward progression, transitions into diagnostics or medical device roles in search of stability, or shifts into contract roles that made it harder to transition back into full-time gigs. Some left pharma entirely. Others stayed adjacent, building valuable experience, but outside the traditional pharma sales path.
Pharma is still hard to break into – or back into
Even today, pharma remains a challenging industry to enter without the right timing, the right network, and prior pharma-specific experience. Hiring managers often default to familiar backgrounds and known therapeutic expertise, which can make it difficult for capable mid-career professionals with adjacent experience to re-enter the space.
Why this is a worrying trend
At a surface level, the missing millennial middle can look like a routine hiring challenge: one more tough-to-fill segment in an already competitive market. But the downstream effects run deeper, especially for life sciences commercial organizations built to scale and sustain performance over time.
This is because mid-career professionals often occupy the most demanding roles on a team. They are:
- Experienced enough to operate independently
- Trusted to manage complex territories or key accounts
- Frequently viewed as the next generation of people leaders
When this layer is thin, companies are forced into compromises, either stretching early-career talent before they are ready, or pulling more senior professionals into roles that don’t always align with compensation expectations or long-term goals.
This impact is felt in mentorship and development.
Mid-career professionals are typically the day-to-day coaches, translating strategy into execution, reinforcing best practices, and helping newer reps navigate real-world challenges. Without that layer, early-career talent has fewer reference points, and senior leaders often absorb more coaching responsibility than is sustainable.
There is also a risk around knowledge transfer.
Mid-career professionals serve as a bridge between institutional knowledge and the next generation of talent. When that bridge is missing, organizations risk losing continuity, from field insights and customer relationships to cultural norms and ways of working. Over time, that loss introduces friction and inconsistency.
A thin middle today affects bench strength tomorrow.
Fewer mid-career professionals means fewer ready-now candidates for future leadership roles, longer ramp times when managers move on, and more reactive hiring at critical moments. In an industry where launches, portfolio shifts, and market dynamics shift quickly, bench strength is not just a nice-to-have, but foundational.
What employers and hiring managers can do
Employers and hiring managers play an important role in strengthening this critical layer of the life sciences workforce.
Some of the key steps they can take include:
STEP 1
Widening the lens on what “qualified” looks like
Many organizations still rely on narrow filters, such as pharma-only backgrounds, uninterrupted tenure, or purely permanent roles. While those criteria feel safe, they can unintentionally exclude capable mid-career professionals who bring strong performance, adaptability, and adjacent industry experience.
STEP 2
Being thoughtful about how contract experience is evaluated
For many candidates, contract roles were not a preference but a response to market realities. Long-term success in contract positions can be a signal of resilience, consistency, and the ability to deliver without extended onboarding. When viewed through the right lens, this experience can strengthen a team rather than dilute it.
STEP 3
Investing intentionally in development and progression
Mid-career professionals thrive when expectations and pathways are clear. Defined steps from representative to senior contributor to people leader help rebuild bench strength and reduce the pressure of reactive hiring. Development at this stage is not just retention-focused, but foundational to long-term performance.
STEP 4
Challenging assumptions about “fit”
Experience in medical device, diagnostics, or other adjacent spaces can translate well into pharma when supported appropriately. In some cases, a strong seller with the right mindset and coaching can ramp faster than someone with a narrower but more familiar background.
What candidates can do
While many of the forces behind this gap are outside any one individual’s control, there are ways candidates can proactively position themselves for success, including:
STEP 1
Getting clear and intentional about how you show up on paper
An up-to-date, well-structured resume is foundational. At this stage, clarity matters more than length. Clearly outlining scope, performance, and progression helps hiring managers quickly understand where you are in your career and where you’re headed.
STEP 2
Building visible commitment to pharma – especially if you’re pivoting in or back in
For candidates transitioning into pharmaceutical sales mid-career, demonstrating initiative goes a long way. Foundational learning and certifications (such as CNPR Pharmaceutical Sales Training, Pharmaceutical Representative Certification (PRC®), or Certified Medical Representative (CMR)) can help bridge gaps and signal seriousness about the space, even without direct pharma experience. In some cases, placing relevant certifications prominently on your resume can make a meaningful difference.
STEP 3
Being thoughtful – but persistent – in your search
Most pharmaceutical sales roles live on LinkedIn, and consistency matters. Following target companies, applying broadly, and keeping an eye out for associate or training programs at larger organizations can all open doors. Many entry and early commercial roles value transferable skills just as much as direct pharma experience.
STEP 4
Networking strategically, not passively
In pharma, relationships still matter. Reaching out to recruiters, HR partners, or current employees with a clear, concise message about your background and motivation can help you stand out. Referrals remain one of the strongest ways to get traction, and thoughtful outreach often carries more weight than another application in a crowded inbox.
STEP 5
Reframing adjacent and contract experience with confidence
For candidates who’ve spent time in medical device, diagnostics, B2B sales, or contract roles, the key is translation. These experiences can demonstrate adaptability, resilience, and strong sales fundamentals when clearly connected back to pharma’s expectations.
This process can be slow and discouraging, particularly for experienced professionals who are used to moving forward quickly. However, gaining momentum in a high-performance adjacent role can be a strategic move rather than a setback. Many organizations actively recruit proven sellers from outside traditional pharma paths.
Further reading: We’ve previously shared practical guidance for candidates in our how-to guide, 7 Tips to Break Into Pharmaceutical Sales
Meeting in the middle
The missing middle wasn’t created by any one decision, and it won’t be solved by one person or organization alone. Candidates are navigating non-linear career paths shaped by market forces, while employers are balancing performance, risk, and long-term team health in a competitive environment.
Rebuilding this critical layer of the life sciences workforce requires meeting in the middle – with candidates investing intentionally in readiness and clarity, and hiring managers expanding how they evaluate experience, potential, and fit.
That’s where Mix Talent comes in. We partner closely with life sciences organizations to build talented commercial teams, and we work alongside candidates to help them find the right next opportunity, not just the next job.
